31/08 Stock to watch --- ASTM





Aastrom Biosciences, Inc., a development stage company, develops
patient-specific products for the repair or regeneration of human tissues,
utilizing its proprietary adult stem cell technology. Its lead products
include tissue repair cells (TRCs), which are a mixture of bone
marrow-derived adult stem and progenitor cells, produced outside of the body
or 'ex vivo' from a small amount of bone marrow taken from the patient. The
company also offers AastromReplicell System, a patented, integrated system
of instrumentation and single-use consumable kits for the commercial
production of human cells. Aastrom Biosciences is developing TRCs for the
treatment of severe bone fractures, ischemic vascular disease, jaw
reconstruction, and spine fusion. It also focuses on the utilization of TRCs
in the areas of bone regeneration and vascular regeneration in limb ischemia
resulting from diabetes and other diseases. The company has a strategic
alliance with Musculoskeletal Transplant Foundation to develop and
commercialize treatments for the regeneration of tissues, such as bone and
cartilage; and a collaboration agreement with Orthovita, Inc. to develop
products for the orthopedics market using Orthovita's synthetic ceramic
matrices and ceramic-collagen matrices, and Aastrom's proprietary bone
marrow-derived cells TRC. Aastrom Biosciences was incorporated in 1989 and
is headquartered in Ann Arbor, Michigan.



.



Relevant Pages

  • Re: Trader Alert --- ASTM up 4.35 %
    ... Aastrom Biosciences, Inc., a development stage company, develops ... patient-specific products for the repair or regeneration of human tissues, ... marrow-derived adult stem and progenitor cells, ... treatment of severe bone fractures, ischemic vascular disease, jaw ...
    (misc.invest.stocks)
  • Trader Alert --- ASTM
    ... Aastrom Biosciences, Inc., a development stage company, develops ... marrow-derived adult stem and progenitor cells, ... from a small amount of bone marrow taken from the patient. ... in the areas of bone regeneration and vascular regeneration in limb ischemia ...
    (misc.invest.stocks)
  • 30/08 --- ASTM
    ... Aastrom Biosciences, Inc., a development stage company, develops ... marrow-derived adult stem and progenitor cells, ... or 'ex vivo' from a small amount of bone marrow taken from the patient. ... in the areas of bone regeneration and vascular regeneration in limb ischemia ...
    (misc.invest.stocks)
  • Re: 31/08 Stock to watch --- ASTM up 4.27 %
    ... Aastrom Biosciences, Inc., a development stage company, develops ... production of human cells. ... commercialize treatments for the regeneration of tissues, ...
    (misc.invest.stocks)
  • Re: 31/08 Stock to watch --- ASTM up 2.56 %
    ... Aastrom Biosciences, Inc., a development stage company, develops ... patient-specific products for the repair or regeneration of human tissues, ... marrow-derived adult stem and progenitor cells, ... treatment of severe bone fractures, ischemic vascular disease, jaw ...
    (misc.invest.stocks)

Loading